Risk of upper gastrointestinal bleeding in a cohort of new users of low-dose ASA for secondary prevention of cardiovascular outcomes

Frontiers in Pharmacology

Volumn OCT, Issue , 2010, Pages

  Soriano, Lucía Cea ^a   García Rodríguez, Luis A ^a  

^a Department of Pharmacoepidemiology   (Spain)

Author keywords

Acetylsalicylic acid; Case control; Secondary prevention; Upper gastrointestinal bleeding

Indexed keywords

EID: 84865980929     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2010.00126     Document Type: Article

References (28)

1. Antithrombotic Trialists' Collaboration. (2002). Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myo- cardial infarction, and stroke in high risk patients. BMJ 324, 71-86.
2. Bhatt, D. L., Scheiman, J., Abraham, N. S., Antman, E. M., Chan, F. K., Furberg, C. D., Johnson, D. A., Mahaffey, K. W., and Quigley, E. M. (2008). ACCF/ACG/AHA 2008 expert con- sensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 118, 1894-1909.
3. Bourke, A., Dattani, H., and Robinson, M. (2004). Feasibility study and meth- odology to create a quality-evaluated database of primary care data. Inform. Prim. Care 12, 171-177.
4. Collet, J. P., Montalescot, G., Blanchet, B., Tanguy, M. L., Golmard, J. L., Choussat, R., Beygui, F., Payot, L., Vignolles, N., Metzger, J. P., and Thomas, D. (2004). Impact of prior use or recent with- drawal of oral antiplatelet agents on acute coronary syndromes. Circulation 110, 2361-2367.
5. De Abajo, F. J., and García Rodríguez, L. A. (2001). Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations. BMC Clin. Pharmacol. 1, 1.
6. First Data Bank. (2010). MULTILEX for Primary Care. Available from: http://www.firstdatabank.co.uk/uploads/files/MultilexDDF%20for%20Primary%20Care.pdf (Accessed 25 January 2010).
7. García Rodríguez, L. A., and Barreales Tolosa, L. (2007). Risk of upper gas- trointestinal complications among users of traditional NSAIDs and COXIBs in the general population. Gastroenterology 132, 498-506.
8. García Rodríguez, L. A., Cea Soriano, L., Martín-Merino, E., and Johansson, S. (2009). Discontinuation of low- dose acetylsalicylic acid treatment for secondary prevention of cardio- vascular outcomes is associated with an increased risk of myocardial infarc- tion. Circulation 120, S405.
9. García Rodríguez, L. A., Hernández-Díaz, S., and de Abajo, F. J. (2001). Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies. Br. J. Clin. Pharmacol. 52, 563-571.
10. Hallas, J., Dall, M., Andries, A., Andersen, B. S., Aalykke, C., Hansen, J. M., Andersen, M., and Lassen, A. T. (2006). Use of single and combined anti- thrombotic therapy and risk of seri- ous upper gastrointestinal bleeding: population based case-control study. BMJ 333, 726.
11. Hernández-Díaz, S., and García Rodríguez, L. A. (2002). Incidence of serious upper gastrointestinal bleeding/ perforation in the general population: review of epidemiologic studies. J. Clin. Epidemiol. 55, 157-163.
12. Hernández-Díaz, S., and García Rodríguez, L. A. (2006). Cardioprotective aspirin users and their excess risk of upper gastrointestinal complications. BMC Med. 4, 22.
13. Ibáñez, L., Vidal, X., Vendrell, L., Moretti, U., and Laporte, J. R. (2006). Upper gastrointestinal bleeding associated with antiplatelet drugs. Aliment. Pharmacol. Ther. 23, 235-242.
14. Kelly, J. P., Kaufman, D. W., Jurgelon, J. M., Sheehan, J., Koff, R. S., and Shapiro, S. (1996). Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered prod- uct. Lancet 348, 1413-1416.
15. King, S. B., 3rd, Smith, S. C., Jr., Hirshfeld, J. W., Jr., Jacobs, A. K., Morrison, D. A., Williams, D. O., Feldman, T. E., Kern, M. J., O'Neill, W. W., Schaff, H. V., Whitlow, P. L., Adams, C. D., Anderson, J. L., Buller, C. E., Creager, M. A., Ettinger, S. M., Halperin, J. L., Hunt, S. A., Krumholz, H. M., Kushner, F. G., Lytle, B. W., Nishimura, R., Page, R. L., Riegel, B., Tarkington, L. G., and Yancy, C. W. (2008). 2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American college of cardiology/ American heart association task force on practice guidelines: 2007 writing group to review new evidence and update the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention, writing on behalf of the 2005 writing commit- tee. Circulation 117, 261-295.
16. Lanas, A., Bajador, E., Serrano, P., Fuentes, J., Carreno, S., Guardia, J., Sanz, M., Montoro, M., and Sainz, R. (2000). Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastroin- testinal bleeding. N. Engl. J. Med. 343, 834-839.
17. Lanas, A., García Rodríguez, L. A., Arroyo, M. T., Bujanda, L., Gomollón, F., Forné, M., Aleman, S., Nicolas, D., Feu, F., González-Pérez, A., Borda, A., Castro, M., Poveda, M. J., and Arenas, J. (2007). Effect of antisecretory drugs and nitrates on the risk of ulcer bleeding associated with nonsteroidal anti-inflammatory drugs, antiplate- let agents, and anticoagulants. Am. J. Gastroenterol. 102, 507-515.
18. Lanas, A., García Rodríguez, L. A., Arroyo, M. T., Gomollón, F., Feu, F., González-Pérez, A., Zapata, E., Bástida, G., Rodrigo, L., Santolaria, S., Güell, M., de Argila, C. M., Quintero, E., Borda, F., and Piqué, J. M. (2006). Risk of upper gastrointestinal ulcer bleeding associ- ated with selective cyclo-oxygenase-2 inhibitors, traditional non- aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut 55, 1731-1738.
19. Lanas, A., and Scheiman, J. (2007). Low- dose aspirin and upper gastrointesti- nal damage: epidemiology, prevention and treatment. Curr. Med. Res. Opin. 23, 163-173.
20. Lewis, J. D., Schinnar, R., Bilker, W. B., Wang, X., and Strom, B. L. (2007). Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol. Drug. Saf. 16, 393-401.
21. Ma, L., Elliott, S. N., Cirino, G., Buret, A., Ignarro, L. J., and Wallace, J. L. (2001). Platelets modulate gastric ulcer healing: role of endostatin and vascular endothelial growth factor release. Proc. Natl. Acad. Sci. U.S.A. 98, 6470-6475.
22. Maulaz, A. B., Bezerra, D. C., Michel, P., and Bogousslavsky, J. (2005). Effect of discontinuing aspirin therapy on the risk of brain ischemic stroke. Arch. Neurol. 62, 1217-1220.
23. O'Neil, M., Payne, C., and Read, J. (1995). Read Codes Version 3: a user led ter-minology. Methods Inf. Med. 34, 187-192.
24. Patrono, C., García Rodríguez, L. A., Landolfi, R., and Baigent, C. (2005). Low-dose aspirin for the prevention of atherothrombosis. N. Engl. J. Med. 353, 2373-2383.
25. Sacco, R. L., Adams, R., Albers, G., Alberts, M. J., Benavente, O., Furie, K., Goldstein, L. B., Gorelick, P., Halperin, J., Harbaugh, R., Johnston, S. C., Katzan, I., Kelly-Hayes, M., Kenton, E. J., Marks, M., Schwamm, L. H., and Tomsick, T. (2006). Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline. Stroke 37, 577-617.
26. Smith, S. C. Jr., Allen, J., Blair, S. N., Bonow, R. O., Brass, L. M., Fonarow, G. C., Grundy, S. M., Hiratzka, L., Jones, D., Krumholz, H. M., Mosca, L., Pearson, T., Pfeffer, M. A., and Taubert, K. A. (2006). AHA/ACC guidelines for secondary prevention for patients with coronary and other atherosclerotic vascular disease: 2006 update endorsed by the National Heart, Lung, and Blood Institute. J. Am. Coll. Cardiol. 47, 2130-2139.
27. Stuart-Buttle, C. D., Read, J. D., Sanderson, H. F., and Sutton, Y. M. (1996). A lan- guage of health in action: read Codes, classifications and groupings. Proc. AMIA. Annu. Fall Symp. 75-79.
28. Weil, J., Colin-Jones, D., Langman, M., Lawson, D., Logan, R., Murphy, M., Rawlins, M., Vessey, M., and Wainwright, P. (1995). Prophylactic aspirin and risk of peptic ulcer bleed- ing. BMJ 310, 827-830